Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$512M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
| 3 |
Toronto Dominion Bank
TD
|
+$275M |
| 4 |
Shopify
SHOP
|
+$265M |
| 5 |
TC Energy
TRP
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$363M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$202M |
| 3 |
Restaurant Brands International
QSR
|
+$198M |
| 4 |
Canadian Natural Resources
CNQ
|
+$121M |
| 5 |
Invitation Homes
INVH
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.93% |
| 2 | Technology | 14.17% |
| 3 | Miscellaneous | 12.5% |
| 4 | Healthcare | 8.07% |
| 5 | Communication Services | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CHNG
3476
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $45K | ﹤0.01% |
4,569
+4,127
| +934% | +$46.4K |
2019 Q4
2 quarters
|
|
|
QEP
3477
DELISTED
QEP RESOURCES, INC.
QEP
| $45K | ﹤0.01% |
39,345
+9,172
| +30% | +$8.56K |
2013 Q2
28 quarters
|
|
|
BTAI
3478
DELISTED
BioXcel Therapeutics
BTAI
| $44K | ﹤0.01% |
+53
| New | +$34.6K |
2020 Q2
0 quarters
|
|
3479
Corbus Pharmaceuticals
CRBP
$123M
| $44K | ﹤0.01% |
188
-178
| -49% | -$36K |
2018 Q2
8 quarters
|
|
|
JPI
3480
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
| $44K | ﹤0.01% |
+2,000
| New | +$40.7K |
2020 Q2
0 quarters
|
|
|
CBAY
3481
DELISTED
Cymabay Therapeutics
CBAY
| $44K | ﹤0.01% |
13,309
+11,642
| +698% | +$33.6K |
2018 Q2
8 quarters
|
|
|
ABTX
3482
DELISTED
Allegiance Bancshares
ABTX
| $44K | ﹤0.01% |
1,996
+1,192
| +148% | +$29.2K |
2017 Q1
13 quarters
|
|
|
TPCO
3483
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $44K | ﹤0.01% |
4,752
+1,520
| +47% | +$13.6K |
2018 Q2
8 quarters
|
|
3484
HF Foods Group
HFFG
$92.3M
| $43K | ﹤0.01% |
+5,025
| New | +$36.6K |
2020 Q2
0 quarters
|
|
|
OGCP
3485
Empire State Realty Series 60
OGCP
| $43K | ﹤0.01% |
6,770
-425
| -6% | -$3.17K |
2013 Q4
26 quarters
|
|
3486
State Street SPDR NYSE Technology ETF
XNTK
$2.1B
| $43K | ﹤0.01% |
400
| – | – |
2016 Q1
17 quarters
|
|
|
TECX
3487
Tectonic Therapeutic
TECX
$443M
| $43K | ﹤0.01% |
+206
| New | +$42.4K |
2020 Q2
0 quarters
|
|
|
ENZ
3488
DELISTED
Enzo Biochem, Inc.
ENZ
| $43K | ﹤0.01% |
15,972
+2,345
| +17% | +$6.03K |
2019 Q2
4 quarters
|
|
|
SCU
3489
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $43K | ﹤0.01% |
3,439
+1,439
| +72% | +$18.4K |
2019 Q2
4 quarters
|
|
|
GBT
3490
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $43K | ﹤0.01% |
607
-167
| -22% | -$11.5K |
2017 Q1
13 quarters
|
|
3491
Banc of California
BANC
$2.77B
| $42K | ﹤0.01% |
4,488
-3,325
| -43% | -$33.4K |
2015 Q2
20 quarters
|
|
3492
Clean Energy Fuels
CLNE
$346M
| $42K | ﹤0.01% |
+13,932
| New | +$28.1K |
2020 Q2
0 quarters
|
|
|
NRO
3493
Neuberger Real Estate Securities Income Fund Inc
NRO
$163M
| $42K | ﹤0.01% |
12,162
| – | – |
2019 Q4
2 quarters
|
|
|
TMQ
3494
Trilogy Metals
TMQ
$547M
| $42K | ﹤0.01% |
21,333
| – | – |
2013 Q2
28 quarters
|
|
3495
UroGen Pharma
URGN
$1.98B
| $42K | ﹤0.01% |
1,758
+1,444
| +460% | +$35.3K |
2019 Q2
4 quarters
|
|
3496
Q32 Bio
QTTB
$246M
| $42K | ﹤0.01% |
+151
| New | +$40.2K |
2020 Q2
0 quarters
|
|
|
KMF
3497
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
| $42K | ﹤0.01% |
9,858
| – | – |
2019 Q4
2 quarters
|
|
|
ROCC
3498
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $42K | ﹤0.01% |
5,057
+1,759
| +53% | +$13.6K |
2018 Q2
8 quarters
|
|
|
VRS
3499
DELISTED
Verso Corporation
VRS
| $42K | ﹤0.01% |
3,787
+2,787
| +279% | +$36.5K |
2018 Q2
8 quarters
|
|
|
FRTA
3500
DELISTED
Forterra, Inc
FRTA
| $42K | ﹤0.01% |
3,710
+1,519
| +69% | +$12.5K |
2017 Q1
13 quarters
|
|
Similar funds
Bank of Montreal's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of Montreal held 4,997 positions worth $110B, up 26% from $87.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of Montreal's Q2 2020 filing shows 847 new, 2,326 increased, 1,132 reduced and 338 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 781,910 shares worth $45.7M. The largest sale was Amazon, an estimated $363M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Miscellaneous.
- Bank of Montreal's largest Q2 2020 buy was iShares AAA-A Rated Corporate Bond ETF: 781,910 shares worth $45.7M.
- Bank of Montreal added most to Mastercard in Q2 2020, an estimated $512M increase.
- Bank of Montreal's biggest Q2 2020 reduction was Amazon, cutting an estimated $363M.
- Bank of Montreal fully exited Allergan plc in Q2 2020, selling an estimated $94M.
- Bank of Montreal's ten largest holdings make up 22% of its $110B portfolio in Q2 2020.
- Bank of Montreal opened 847 new positions and closed 338 in Q2 2020.
- Bank of Montreal's portfolio value rose 26% quarter-over-quarter to $110B.
Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.